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Which uremic toxins are making our patient sick?
Confounding factors (pre-existing CV disease)
Large inter-patient variability
Inability to decrease a single compound
Complex and multifactorial interplay between different 
key elements, present for longer time
Which uremic toxins are making our patient sick?






Enhancing uremic solute removal improves growth
In pediatrics?
UToPaed study: uremic toxins in pediatric CKD
more advanced and appropriate tools 
to improve management of children 
with CKD 
Pediatric reference frame 
50 healthy children
65 children CKD stage 1-5 (not on dialysis)
170 children hemodialysis
6 protein-bound uremic toxins
4 small water-soluble uremic toxins
2 middle molecules
Healthy
CKD 1-5 Maintenance HD
Ensure use of biologically relevant uremic toxin levels 
in experimental studies 
Allow proper design of studies
Snauwaert et al. 2018 (NDT), Snauwaert et al. 2018 (Ped Nephrol), Snauwaert et al. 2019 (Toxins)
Results from observational study to be announced soon
Uremic toxins, how to clear them?
PLASMA










Total solute removal (mass)
DIALYZER
Solute transport in the dialyzer
Clearance and extraction ratio ≈ blood flow + membrane + dialysate flow 
Adding convection to 
diffusion
Dialyzer fiber length, 
diameter and permeability
Eloot et al., Comp Meth Biomech Biomed Eng 2006; Leypoldt et al., Kidney Int, 1999  
DIALYZER
Solute transport in the dialyzer
Diffusion = well established removal strategy 
of free fraction protein-bound uremic toxins 
Meyer et al., Seminars in dialysis 2011; Sirich et al., NDT, 2012; Meert et al., NDT, 2009
TACurea decreases by 15% TACsolute decreases by 50%
Larger membrane & higher Qd
Solute transport in the dialyzer
Dialysate Blood Dialysate Blood Dialysate Blood
Post-HDF High flux HD Low flux HD
37 42 18
Research question: does post-HDF decrease levels of protein-bound uremic toxins ?
baseline
12 months










PROTEIN-BOUND UREMIC TOXINSMIDDLE MOLECULES
Snauwaert et al., NDT, 2020 Apr 1;35(4):648-656.
















Eloot et al., Seminars in Dialysis, 2012
PLASMA
PATIENT
Solute transport in the patient




Solute transport in the patient
Eloot et al., PLOS one, 2016
Dialyzer clearance shows an
inverse relation with % 
protein-binding 




Solute transport in the patient




= slow transport into the plasma. β2M
Snauwaert et al., NDT, 2020 Apr 1;35(4):648-656.
Solute transport at the dialyzer














Snauwaert et al. 2018 (Ped Nephrol)
Eloot et al., Kidney Int, 2016





Alternative strategies to decrease uremic toxicity?
MEMBRANES WITH ADSORPTIVE CAPACITY
PRESERVATION OF RESIDUAL KIDNEY 
FUNCTION
Jansens et al. 2016; Tijink et al. 2014
DIETARY FIBER, PRE-, PRO, and
SYNBIOTICS
Take-home messages
Question 1: Which statement is true? 
A. Solute transport at the dialyzer is solely dependent on Qd and Qb
B. Solute removal at the dialyzer is the only determinant of uremic solute
removal
C. With even the most recent advances, it seems that small solute removal in 
the dialyzer is close to its optimum. 
D. The main removal strategy of protein-bound uremic toxins is convection
Answers Question 1: Which statement is true? 
A. Solute transport at the dialyzer is solely dependent on Qd and Qb
B. Solute removal at the dialyzer is the only determinant of uremic solute
removal
C. With even the most recent advances, it seems that small solute removal
in the dialyzer is close to its optimum. 
D. The main removal strategy of protein-bound uremic toxins is convection
+ membrane
FALSE + Patient kinetics 
FALSE = Diffusion of free fraction
A. eGFR is a good predictor of overall uremic toxin accumulation
B. Kt/V is a good marker of dialysis adequacy as it reflects overall uremic
toxin removal
C. Solute transport in the patient limits the increase of performance 
with the traditional dialytic approaches.
D. Intercompartiment clearance (K12) of urea and β2-microglobuline are 
similar, e.g. 800mL/min
Question 2: Which statement is true?
A. eGFR is a good predictor of overall uremic toxin accumulation
B. Kt/V is a good marker of dialysis adequacy as it reflects overall uremic
toxin removal
C. Solute transport in the patient limits the increase of performance 
with the traditional dialytic approaches.
D. Intercompartiment clearance (K12) of urea and β2-microglobuline are 
similar, e.g. 800mL/min
Answers Question 2: Which statement is true?
FALSE
Only partially!
β2M = 50mL/min, only 6% of K12 of urea
TEAMWORK DIVIDES THE TASK & DOUBLE THE SUCCESS

































Members of advisory board
THANK YOU!
